





- Stock: In Stock
- Model: 178643
0% Customers recommend this product
-
5 Awesome0%
-
4 Great0%
-
3 Average0%
-
2 Bad0%
-
1 Poor0%
Reviews Over Spiolto Respimat solution for ing. 2.5mkg/2.5mkg case. 4 ml (60 inhalations +1ing. Respimat) No. 1
- (0)
Total Reviews (0)
click here write review to add review for this product.
Report this review.
Description
Solution for inhalations Spiolto Respimat is shown as the supporting broncholitic therapy for relief of symptoms at adult patients with a chronic obstructive disease of easy (HOBL).
Structure
Active ingredients: tiotropiya, olodaterol;
1 inhalation contains 2.5 mkg a tiotropiya (in the form of monohydrate bromide), 2.5 mkg to an olodaterol (in the form of a hydrochloride);
Excipients: a benzalkoniya chloride, sodium edetat a dihydrate, water the purified, hydrochloric acid 1M.
Contraindication
Hypersensitivity to active ingredients or other components of medicine.
Hypersensitivity to atropine or its derivatives, for example to an ipratropiya or an oksitropiya in the anamnesis.
Route of administration Medicine is intended toby
only for inhalation application. The cartridge can be used only with the RESPIMAT inhalation device.
Two breaths by means of an inhaler of RESPIMAT contain one dose.
Feature of application
Pregnant
Should avoid use of medicine.
byChildren
it is not applied.
Drivers
With care.
Overdose
High doses a tiotropiya can cause anticholinergic signs and symptoms.
Overdose olodateroly can leadto 2 expressed the effects typical for β - adrenomimetik, for example, to ischemia of a myocardium, arterial hypertension or hypotension, tachycardia, arrhythmia, heartbeat, dizziness, nervousness, insomnia, concern, a headache, a tremor, dryness in a mouth, a muscular spasm, nausea, fatigue, to deterioration in health, a hypopotassemia, hyperglycemia and a metabolic acidosis.
Should stop use of the medicine Spiolto Respimat. The supporting and symptomatic therapy is shown.
Side effects
Serious side reactions of anticholinergic character include glaucoma, a lock, impassability of intestines, including paralytic impassability of intestines and an ischuria.
InteractionSimultaneous application a bromide tiotropiya with other anticholinergics was not investigated by
and therefore it is not recommended.
Simultaneous use of other adrenergic medicines (independently or as a part of combination therapy) can enhance undesirable effects of the medicine Spiolto Respimat.
Storage conditionsto Store
at a temperature not above 25 °C. Not to freeze! to Store
out of children's reach!
Expiration date - 3 years.
Specifications
Characteristics | |
Active ingredients | Olodaterola hydrochloride, Tiotropiya bromide |
Applicant | Boehringer Ingelheim |
Code of automatic telephone exchange | R03AL06 Olodaterol and tiotropiya bromide |
Interaction with food | It doesn't matter |
Light sensitivity | Not sensitive |
Market status | Original |
Origin | Chemical |
Prescription status | According to the prescription |
Primary packing | cartridge |
Producer | BOEHRINGER INGELCHEIM PHARM GMBH AND TO |
Quantity in packing | 4 ml |
Release form | solution for inhalations |
Route of administration | For inhalation |
Sign | Import |
Storage temperature | from 5 °C to 30 °C |
Trade name | Spiolto |